Canopy Growth (CGC) Expected to Post Quarterly Earnings on Friday

Canopy Growth (NASDAQ:CGC) is projected to announce its Q1 2027 results before the market opens on Friday, August 7th. Analysts expect Canopy Growth to post earnings of ($0.04) per share and revenue of $58.2080 million for the quarter. Interested persons can check the company’s upcoming Q1 2027 earning report page for the latest details on the call scheduled for Friday, August 7, 2026 at 10:00 AM ET.

Canopy Growth (NASDAQ:CGC) last announced its earnings results on Monday, June 15th. The company reported ($0.17) EPS for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.11). The company had revenue of $51.22 million for the quarter, compared to analyst estimates of $53.43 million. Canopy Growth had a negative net margin of 75.27% and a negative return on equity of 26.95%. On average, analysts expect Canopy Growth to post $-0 EPS for the current fiscal year and $-0 EPS for the next fiscal year.

Canopy Growth Stock Up 0.0%

CGC opened at $0.93 on Thursday. The company has a quick ratio of 2.64, a current ratio of 3.34 and a debt-to-equity ratio of 0.31. The firm has a market cap of $417.79 million, a P/E ratio of -1.58 and a beta of 0.81. Canopy Growth has a 52 week low of $0.84 and a 52 week high of $2.38. The business’s fifty day simple moving average is $0.97 and its 200 day simple moving average is $1.04.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised shares of Canopy Growth from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, July 29th. Two investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold”.

Insiders Place Their Bets

In other news, CEO Luc Mongeau sold 135,231 shares of the firm’s stock in a transaction on Wednesday, June 17th. The shares were sold at an average price of $0.97, for a total value of $131,174.07. Following the transaction, the chief executive officer owned 1,723,913 shares of the company’s stock, valued at approximately $1,672,195.61. This trade represents a 7.27% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Christelle Gedeon sold 58,994 shares of the business’s stock in a transaction that occurred on Wednesday, June 17th. The stock was sold at an average price of $0.97, for a total value of $57,224.18. Following the transaction, the insider directly owned 705,506 shares in the company, valued at $684,340.82. This trade represents a 7.72% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 224,958 shares of company stock worth $217,137. Insiders own 0.16% of the company’s stock.

Institutional Trading of Canopy Growth

A number of hedge funds have recently made changes to their positions in the company. Tidal Investments LLC increased its stake in Canopy Growth by 31.5% during the 2nd quarter. Tidal Investments LLC now owns 5,033,793 shares of the company’s stock worth $6,141,000 after buying an additional 1,204,530 shares during the period. Millennium Management LLC increased its position in shares of Canopy Growth by 196.9% during the third quarter. Millennium Management LLC now owns 3,137,696 shares of the company’s stock worth $4,579,000 after acquiring an additional 2,080,994 shares during the last quarter. Two Sigma Investments LP purchased a new stake in shares of Canopy Growth during the third quarter worth about $1,767,000. Headlands Technologies LLC lifted its stake in shares of Canopy Growth by 355.0% in the fourth quarter. Headlands Technologies LLC now owns 987,809 shares of the company’s stock worth $1,126,000 after acquiring an additional 770,717 shares in the last quarter. Finally, Jones Financial Companies Lllp lifted its stake in shares of Canopy Growth by 10,308.3% in the first quarter. Jones Financial Companies Lllp now owns 969,533 shares of the company’s stock worth $882,000 after acquiring an additional 960,218 shares in the last quarter. Hedge funds and other institutional investors own 3.33% of the company’s stock.

Canopy Growth Company Profile

Canopy Growth Corporation is a leading Canadian cannabis company engaged in the production, distribution and sale of both medical and recreational cannabis products. Headquartered in Smiths Falls, Ontario, the company cultivates a diversified portfolio of offerings that includes dried flower, pre-rolled joints, oils, softgel capsules and edibles. Canopy Growth also markets derivative products such as beverages and wellness formulations under a range of brands, aiming to serve both patient and adult-use markets.

The company operates through multiple subsidiaries, including Tweed Inc, Spectrum Therapeutics and Tokyo Smoke, each targeting distinct consumer segments.